January 2023 FDA Recall Metoprolol Succinate by Amerisource Health Services Llc
D-0269-2023 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on January 11, 2023 for the product Metoprolol Succinate. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0269-2023

Reason for Recall
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Initiated
01-11-2023
Reported
02-22-2023
Quantity
(a) 6670 100-count (b) 2666 500-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories

Batch or Lot Expiration Information

Lot# Lots: (a) 21143211, EXP 03/31/2023; (b) 21143185, 21143193, EXP 02/28/2023